Sanofis aventis French based pharmaceuticals found a solution for reducing the body weight with the drug “acomplia”. this carboxamide drug’s chemical formula is C22H21Cl3N4O.this drug though has many advantages it was not accepted in some countries because of the following reasons like it affects the central nervous system leading to diseases like multiple sclerosis, Alzheimer’s disease, Huntington’s disease , Parkinson’s disease, amyotrophic lateral sclerosis etc. it was legally registered and sold in the market of united kingdom first. Then it occurrence level rose in some of the European countries like Denmark, Ireland, Germany, Finland, Norway, Belgium, Sweden. Now acomplia is available in 60 countries.
Other than the anti obesity action it also excels in it performance of reducing heart problem and related threats. This is due to the fact that acomplia increases HDL (good cholesterol level) and reduces triglycerides (bad cholesterol). It is found that it has ability to reduce 15 % of triglycerides content in our body. A recent trial shows that using 20 mg of these chemical drugs per day leads to reduction in weight, blood sugar level has increased, blood lipid profile also increases and it improves the systolic blood pressure. Since FDA approval is still in stay many Americans are purchasing this in online these days. Acomplia acts as a contrary agonist for the CBI cannabinoid receptors.